Healthy Volunteers (HV)
3
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
2027
Eilean TherapeuticsZE66-0205
argenxAdimanebart IV
Vertero TherapeuticsVT-5006
Clinical Trials (3)
Total enrollment: 168 patients across 3 trials
A First-in-Human Study of ZE66-0205 in Healthy Volunteers
Start: Aug 2026Est. completion: Aug 202732 patients
Phase 1Not Yet Recruiting
A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants
Start: Jun 2026Est. completion: Dec 202652 patients
Phase 1Recruiting
Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease
Start: Oct 2025Est. completion: Sep 202684 patients
Phase 1Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 168 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.